Biotechnology Portfolio Biotechnology Fund Cash Position Weight
| FBIOX Fund | USD 20.50 0.29 1.39% |
Biotechnology Portfolio Biotechnology fundamentals help investors to digest information that contributes to Biotechnology Portfolio's financial success or failures. It also enables traders to predict the movement of Biotechnology Mutual Fund. The fundamental analysis module provides a way to measure Biotechnology Portfolio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotechnology Portfolio mutual fund.
Biotechnology |
Biotechnology Portfolio Biotechnology Mutual Fund Cash Position Weight Analysis
Biotechnology Portfolio's Percentage of fund asset invested in cash equivalents or risk-free instruments. About 40% of all global funds carry cash on their balance sheet.
Current Biotechnology Portfolio Cash Position Weight | 0.41 % |
Most of Biotechnology Portfolio's fundamental indicators, such as Cash Position Weight, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotechnology Portfolio Biotechnology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Funds or ETFs that have over 40% of their value invested in low-risk instruments or cash equivalents typically attract conservative investors.
| Competition |
Biotechnology Portfolio Cash Position Weight Component Assessment
In accordance with the recently published financial statements, Biotechnology Portfolio Biotechnology has 0.41% in Cash Position Weight. This is 82.7% lower than that of the Fidelity Investments family and 60.39% lower than that of the Health category. The cash position weight for all United States funds is 96.14% higher than that of the company.
Biotechnology Cash Position Weight Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotechnology Portfolio's direct or indirect competition against its Cash Position Weight to detect undervalued stocks with similar characteristics or determine the mutual funds which would be a good addition to a portfolio. Peer analysis of Biotechnology Portfolio could also be used in its relative valuation, which is a method of valuing Biotechnology Portfolio by comparing valuation metrics of similar companies.Biotechnology Portfolio is currently under evaluation in cash position weight among similar funds.
Fund Asset Allocation for Biotechnology Portfolio
The fund consists of 96.05% investments in stocks, with the rest of investments allocated between different money market instruments and various exotic instruments.Asset allocation divides Biotechnology Portfolio's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
Biotechnology Fundamentals
| Price To Earning | 29.21 X | ||||
| Price To Book | 3.43 X | ||||
| Price To Sales | 7.71 X | ||||
| Annual Yield | 0.01 % | ||||
| Year To Date Return | 17.57 % | ||||
| One Year Return | 40.46 % | ||||
| Three Year Return | 2.47 % | ||||
| Five Year Return | 6.46 % | ||||
| Ten Year Return | 19.82 % | ||||
| Net Asset | 4.78 B | ||||
| Last Dividend Paid | 0.03 | ||||
| Cash Position Weight | 0.41 % | ||||
| Equity Positions Weight | 96.05 % |
About Biotechnology Portfolio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotechnology Portfolio Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotechnology Portfolio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotechnology Portfolio Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Portfolio financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Portfolio security.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |